Drug Search Results
More Filters [+]

Carbasalate calcium

Alternative Names: carbasalate calcium
Latest Update: 2024-10-01
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PA Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Croatia | Iceland | Ireland | Latvia | Netherlands | Poland | Portugal | Romania | Switzerland

Approved Indications: None

Known Adverse Events: None

Company: Leiden University Medical Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Carbasalate calcium

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Hypertension|Atrial Fibrillation|Acute Coronary Syndrome|Stroke

Phase 3: Hypertension|Type 1 Diabetes|Arthritis, Rheumatoid

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

114180

P4

Unknown Status

Stroke

2031-09-02

BA-SCAD

P4

Unknown Status

Unknown

2026-02-28

WOEST 3 trial

P4

Active, not recruiting

Acute Coronary Syndrome|Atrial Fibrillation

2025-02-17

ASPIRETENSION

P4

Completed

Hypertension

2013-10-01

Recent News Events